Menu
GeneBe

11-2909586-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_002555.6(SLC22A18):c.412A>G(p.Met138Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000264 in 1,528,802 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M138I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00028 ( 1 hom. )

Consequence

SLC22A18
NM_002555.6 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.732
Variant links:
Genes affected
SLC22A18 (HGNC:10964): (solute carrier family 22 member 18) This gene is one of several tumor-suppressing subtransferable fragments located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene is imprinted, with preferential expression from the maternal allele. Mutations in this gene have been found in Wilms' tumor and lung cancer. This protein may act as a transporter of organic cations, and have a role in the transport of chloroquine and quinidine-related compounds in kidney. Several alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3479455).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC22A18NM_002555.6 linkuse as main transcriptc.412A>G p.Met138Val missense_variant 5/11 ENST00000649076.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC22A18ENST00000649076.2 linkuse as main transcriptc.412A>G p.Met138Val missense_variant 5/11 NM_002555.6 P1

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
151918
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000280
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000966
AC:
12
AN:
124228
Hom.:
0
AF XY:
0.000117
AC XY:
8
AN XY:
68528
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000261
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000277
AC:
381
AN:
1376884
Hom.:
1
Cov.:
35
AF XY:
0.000241
AC XY:
164
AN XY:
679442
show subpopulations
Gnomad4 AFR exome
AF:
0.0000659
Gnomad4 AMR exome
AF:
0.0000283
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000330
Gnomad4 OTH exome
AF:
0.000401
GnomAD4 genome
AF:
0.000145
AC:
22
AN:
151918
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
8
AN XY:
74234
show subpopulations
Gnomad4 AFR
AF:
0.0000484
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000280
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000423
Hom.:
0
Bravo
AF:
0.000140
ExAC
AF:
0.0000698
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 14, 2023The c.412A>G (p.M138V) alteration is located in exon 5 (coding exon 4) of the SLC22A18 gene. This alteration results from a A to G substitution at nucleotide position 412, causing the methionine (M) at amino acid position 138 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.30
Cadd
Uncertain
25
Dann
Benign
0.96
DEOGEN2
Benign
0.21
T;T;T;T
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.094
FATHMM_MKL
Benign
0.56
D
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.35
T;T;T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Uncertain
2.8
M;M;M;M
MutationTaster
Benign
1.0
D;N;N;N
PrimateAI
Pathogenic
0.88
D
PROVEAN
Uncertain
-2.8
D;D;.;D
REVEL
Benign
0.20
Sift
Uncertain
0.0090
D;D;.;D
Sift4G
Benign
0.13
T;T;.;T
Polyphen
0.92
P;P;P;P
Vest4
0.59
MVP
0.71
MPC
0.32
ClinPred
0.38
T
GERP RS
3.4
Varity_R
0.35
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs753212431; hg19: chr11-2930816; API